Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Biological sex influences antibody responses to routine vaccinations in the first year of life.

Zimmermann P, Perrett KP, Ritz N, Flanagan KL, Robins-Browne R, van der Klis FRM, Curtis N; MIS BAIR group.

Acta Paediatr. 2019 Jul 10. doi: 10.1111/apa.14932. [Epub ahead of print]

PMID:
31610635
2.

Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands.

Vos RA, Mollema L, van Binnendijk R, Veldhuijzen IK, Smits G, Janga-Jansen AVA, Baboe-Kalpoe S, Hulshof K, van der Klis FRM, Melker HE.

Vaccines (Basel). 2019 Oct 1;7(4). pii: E137. doi: 10.3390/vaccines7040137.

3.

Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.

Pasmans H, Schurink-Van't Klooster TM, Bogaard MJM, van Rooijen DM, de Melker HE, Welters MJP, van der Burg SH, van der Klis FRM, Buisman AM.

Vaccine. 2019 Sep 28. pii: S0264-410X(19)31294-0. doi: 10.1016/j.vaccine.2019.09.066. [Epub ahead of print]

PMID:
31575492
4.

The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses.

Zimmermann P, Perrett KP, Messina NL, Donath S, Ritz N, van der Klis FRM, Curtis N.

EClinicalMedicine. 2019 Jul 26;13:21-30. doi: 10.1016/j.eclinm.2019.06.010. eCollection 2019 Aug.

5.

Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.

Hoes J, Knol MJ, Mollema L, Buisman A, de Melker HE, van der Klis FRM.

Vaccine. 2019 Jul 26;37(32):4504-4510. doi: 10.1016/j.vaccine.2019.06.055. Epub 2019 Jul 4.

PMID:
31279563
6.

The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants.

Zimmermann P, Donath S, Perrett KP, Messina NL, Ritz N, Netea MG, Flanagan KL, van der Klis FRM, Curtis N; MIS BAIR group.

Vaccine. 2019 Jun 19;37(28):3735-3744. doi: 10.1016/j.vaccine.2019.03.016. Epub 2019 May 29.

PMID:
31153688
7.

Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands.

Verberk JDM, Vos RA, Mollema L, van Vliet J, van Weert JWM, de Melker HE, van der Klis FRM.

BMC Infect Dis. 2019 May 28;19(1):470. doi: 10.1186/s12879-019-4019-y.

8.

Risk of Measles and Diphtheria Introduction and Transmission on Bonaire, Caribbean Netherlands, 2018.

Vos RA, Mollema L, Kerkhof J, van den Kerkhof JHCT, Gerstenbluth I, Janga-Jansen AVA, Stienstra Y, de Melker HE, van der Klis FRM.

Am J Trop Med Hyg. 2019 Jul;101(1):237-241. doi: 10.4269/ajtmh.18-0824.

9.

A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.

Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, Veldhuijzen IK, Ten Hulscher HI, Kerkhof J, van der Klis FR, van Binnendijk RS.

J Infect Dis. 2019 Apr 23. pii: jiz188. doi: 10.1093/infdis/jiz188. [Epub ahead of print]

PMID:
31112277
10.

Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age.

Brinkman ID, de Wit J, Smits GP, Ten Hulscher HI, Jongerius MC, Abreu TC, van der Klis FRM, Hahné SJM, Koopmans MPG, Rots NY, van Baarle D, van Binnendijk RS.

J Infect Dis. 2019 Apr 11. pii: jiz159. doi: 10.1093/infdis/jiz159. [Epub ahead of print]

11.

The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.

Zimmermann P, Perrett KP, van der Klis FR, Curtis N.

Immunol Cell Biol. 2019 Jul;97(6):577-585. doi: 10.1111/imcb.12246. Epub 2019 Mar 28.

PMID:
30791143
12.

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.

Rice TF, Diavatopoulos DA, Smits GP, van Gageldonk PGM, Berbers GAM, van der Klis FR, Vamvakas G, Donaldson B, Bouqueau M, Holder B, Kampmann B.

Clin Exp Immunol. 2019 Jul;197(1):1-10. doi: 10.1111/cei.13275. Epub 2019 Mar 13.

13.

Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

BMC Med Res Methodol. 2019 Jan 5;19(1):1. doi: 10.1186/s12874-018-0650-3.

14.

Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.

Schurink-van 't Klooster TM, Donken R, Schepp RM, van der Klis FRM, de Melker HE.

Vaccine. 2018 Nov 26;36(49):7580-7587. doi: 10.1016/j.vaccine.2018.10.018. Epub 2018 Oct 28.

15.

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Hoes J, Boef AGC, Knol MJ, de Melker HE, Mollema L, van der Klis FRM, Rots NY, van Baarle D.

Front Public Health. 2018 Jul 27;6:209. doi: 10.3389/fpubh.2018.00209. eCollection 2018.

16.

Detection of Incident Anal High-Risk Human Papillomavirus DNA in Men Who Have Sex With Men: Incidence or Reactivation?

Twisk DE, van der Sande MAB, van Eeden A, Heideman DAM, van der Klis FRM, de Vries HJC, Schim van der Loeff MF.

J Infect Dis. 2018 Aug 24;218(7):1018-1026. doi: 10.1093/infdis/jiy276.

PMID:
29771378
17.

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines.

Altenburg AF, van Trierum SE, de Bruin E, de Meulder D, van de Sandt CE, van der Klis FRM, Fouchier RAM, Koopmans MPG, Rimmelzwaan GF, de Vries RD.

Sci Rep. 2018 Apr 24;8(1):6474. doi: 10.1038/s41598-018-24820-2.

18.

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.

van Ravenhorst MB, den Hartog G, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

PLoS One. 2018 Apr 19;13(4):e0191261. doi: 10.1371/journal.pone.0191261. eCollection 2018.

19.

Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.

Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, Hautvast JLA, Veldhuijzen IK.

Vaccine. 2018 Mar 14;36(12):1664-1672. doi: 10.1016/j.vaccine.2018.01.079. Epub 2018 Feb 14.

20.

Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.

de Vries RD, Nieuwkoop NJ, van der Klis FRM, Koopmans MPG, Krammer F, Rimmelzwaan GF.

J Infect Dis. 2017 Dec 27;217(1):3-11. doi: 10.1093/infdis/jix546.

21.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.

Vaccine. 2018 Jan 8;36(3):400-407. doi: 10.1016/j.vaccine.2017.11.070. Epub 2017 Dec 6.

PMID:
29223483
22.

A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels.

Fisker AB, Nebie E, Schoeps A, Martins C, Rodrigues A, Zakane A, Kagone M, Byberg S, Thysen SM, Tiendrebeogo J, Coulibaly B, Sankoh O, Becher H, Whittle HC, van der Klis FRM, Benn CS, Sie A, Müller O, Aaby P.

Clin Infect Dis. 2018 May 2;66(10):1573-1580. doi: 10.1093/cid/cix1033.

23.

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Woestenberg PJ, King AJ, van Benthem BHB, Donken R, Leussink S, van der Klis FRM, de Melker HE, van der Sande MAB, Hoebe CJPA, Bogaards JA; Medical Microbiological Laboratories and the Public Health Services.

J Infect Dis. 2018 Jan 4;217(2):213-222. doi: 10.1093/infdis/jix582.

24.

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.

Tielemans SMAJ, de Melker HE, Hahné SJM, Boef AGC, van der Klis FRM, Sanders EAM, van der Sande MAB, Knol MJ.

BMJ. 2017 Aug 30;358:j3862. doi: 10.1136/bmj.j3862.

25.

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28.

PMID:
28668575
26.

Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4753-4760. doi: 10.1016/j.vaccine.2017.06.007. Epub 2017 Jun 21.

PMID:
28647167
27.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

28.

The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial.

Nash S, Mentzer AJ, Lule SA, Kizito D, Smits G, van der Klis FR, Elliott AM.

PLoS Negl Trop Dis. 2017 Feb 8;11(2):e0005213. doi: 10.1371/journal.pntd.0005213. eCollection 2017 Feb.

29.

No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.

Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH; Medical Microbiological Laboratories; Public Health Services.

J Infect. 2017 Apr;74(4):393-400. doi: 10.1016/j.jinf.2017.01.007. Epub 2017 Jan 23.

30.

Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated Girls.

Donken R, Schurink-Van't Klooster TM, Schepp RM, van der Klis FR, Knol MJ, Meijer CJ, de Melker HE.

J Infect Dis. 2017 Feb 1;215(3):359-367. doi: 10.1093/infdis/jiw588.

PMID:
28011916
31.

A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus.

Schepp RM, Berbers GA, Ferreira JA, Reimerink JH, van der Klis FR.

J Virol Methods. 2017 Mar;241:15-23. doi: 10.1016/j.jviromet.2016.12.006. Epub 2016 Dec 14.

32.

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FRM, Boland GJ, Sanders EAM, Berbers GAM, Teunis PF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb.

33.

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.

van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA.

Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4.

PMID:
27817957
34.

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, van Benthem BH.

BMC Infect Dis. 2016 Aug 2;16:364. doi: 10.1186/s12879-016-1707-8.

35.

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls.

Donken R, Bogaards JA, van der Klis FR, Meijer CJ, de Melker HE.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1381-93. doi: 10.1080/21645515.2016.1160978. Epub 2016 May 12. Review.

36.

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.

Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L.

PLoS One. 2016 Feb 10;11(2):e0148605. doi: 10.1371/journal.pone.0148605. eCollection 2016.

37.

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?

Stoof SP, Buisman AM, van Rooijen DM, Boonacker R, van der Klis FR, Sanders EA, Berbers GA.

PLoS One. 2015 Oct 12;10(10):e0138665. doi: 10.1371/journal.pone.0138665. eCollection 2015.

38.

Response on Pneumococcal Vaccine in Preterm Infants After Neutral and Acidic Oligosaccharides Supplementation.

van den Berg JP, Westerbeek EA, van der Klis FR, Sanders EA, Berbers GA, van Elburg RM.

Pediatr Infect Dis J. 2015 Sep;34(9):976-82. doi: 10.1097/INF.0000000000000766.

PMID:
26153784
39.

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.

Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA.

Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19.

PMID:
26100925
40.

Effectiveness of human papillomavirus vaccine against incident and persistent infections among young girls: Results from a longitudinal Dutch cohort study.

Mollers M, King AJ, Knol MJ, Scherpenisse M, Meijer CJ, van der Klis FR, de Melker HE.

Vaccine. 2015 May 28;33(23):2678-83. doi: 10.1016/j.vaccine.2015.04.016. Epub 2015 Apr 14.

PMID:
25887090
41.

Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.

Donken R, Knol MJ, Bogaards JA, van der Klis FR, Meijer CJ, de Melker HE.

J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21. Review.

PMID:
25709084
42.

HPV seroconversion following anal and penile HPV infection in HIV-negative and HIV-infected MSM.

Mooij SH, Landén O, van der Klis FR, van der Sande MA, de Melker HE, Xiridou M, van Eeden A, Heijman T, Speksnijder AG, Snijders PJ, Schim van der Loeff MF.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2455-61. doi: 10.1158/1055-9965.EPI-14-0199. Epub 2014 Aug 28.

43.

Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers.

Stoof SP, van der Klis FR, van Rooijen DM, Knol MJ, Sanders EA, Berbers GA.

PLoS One. 2014 Jun 25;9(6):e100651. doi: 10.1371/journal.pone.0100651. eCollection 2014.

44.

No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM.

Mooij SH, Landén O, van der Klis FR, van der Sande MA, de Melker HE, Coutinho RA, van Eeden A, van Rooijen MS, Meijer CJ, Schim van der Loeff MF.

J Infect. 2014 Oct;69(4):375-86. doi: 10.1016/j.jinf.2014.06.003. Epub 2014 Jun 12.

PMID:
24931579
45.

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.

Doedée AM, Boland GJ, Pennings JL, de Klerk A, Berbers GA, van der Klis FR, de Melker HE, van Loveren H, Janssen R.

PLoS One. 2014 Jun 4;9(6):e98175. doi: 10.1371/journal.pone.0098175. eCollection 2014.

46.

Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.

van den Berg JP, Westerbeek EA, Smits GP, van der Klis FR, Berbers GA, van Elburg RM.

PLoS One. 2014 Apr 11;9(4):e94714. doi: 10.1371/journal.pone.0094714. eCollection 2014.

47.

Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men.

van Rijn VM, Mooij SH, Mollers M, Snijders PJ, Speksnijder AG, King AJ, de Vries HJ, van Eeden A, van der Klis FR, de Melker HE, van der Sande MA, van der Loeff MF.

PLoS One. 2014 Mar 20;9(3):e92208. doi: 10.1371/journal.pone.0092208. eCollection 2014.

48.

Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.

van Aar F, de Moraes M, Morré SA, van Bergen JE, van der Klis FR, Land JA, van der Sande MA, van den Broek IV.

Sex Transm Infect. 2014 Aug;90(5):434-40. doi: 10.1136/sextrans-2013-051074. Epub 2014 Feb 28.

PMID:
24583966
49.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR.

Euro Surveill. 2014 Feb 20;19(7):20705.

50.

Seroepidemiology of high-risk HPV in HIV-negative and HIV-infected MSM: the H2M study.

Mooij SH, van der Klis FR, van der Sande MA, Schepp RM, Speksnijder AG, Bogaards JA, de Melker HE, de Vries HJ, Snijders PJ, van der Loeff MF.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1698-708. doi: 10.1158/1055-9965.EPI-13-0460.

Supplemental Content

Loading ...
Support Center